Office-based buprenorphine/naloxone treatment is increasingly available. This study examines patient satisfaction in buprenorphine/naloxone-maintained patients in a primary care office-based setting. The study participants were 142 opioid-dependent subjects.
- Patients gave the highest satisfaction ratings to treatment received in the primary care center and the courteousness of staff members.
- Patients were least satisfied with their interaction with other opioid-dependent patients, referrals to Narcotics Anonymous, and the convenience of the primary care location.
- Female gender and non-white ethnicity/race were significant independent predictors of patient satisfaction even after controlling for other baseline factors.
- Patients who received buprenorphine/naloxone once weekly had higher satisfaction rates than those who received it three times a week.
The overall finding of high levels of satisfaction with office-based buprenorphine/naloxone treatment supports ongoing efforts to expand its use.